Valneva signs advance purchase agreement with bahrain for inactivated covid-19 vaccine vla2001

Saint-herb lain (france ) , december 8 , 2021 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced the signing of an advance purchase agreement with the kingdom of bahrain for the supply of one million doses of the company's inactivated covid-19 vaccine candidate vla2001. this is the second purchase agreement valneva has secured for vla2001 since reporting positive data for its phase 3 clinical trial cov-compare.
VALN Ratings Summary
VALN Quant Ranking